Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

A total of 36 consecutive patients with AML in CR underwent reduced-intensity allogeneic hematopoietic SCT (RISCT) with fludarabine and melphalan conditioning. All patients were ineligible for myeloablative transplantation because of age or comorbidity. In total, 30 patients were in first CR and six...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Bone Marrow Transplant
Main Authors: Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320641/
https://ncbi.nlm.nih.gov/pubmed/21423123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.61
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki